GlassScriptPhysician profile
Jacqueline M Graham
NPI 1013131101
$1,165.47
in general payments reported to CMS, 2019-2025
11 companies · $374 in 2025
The $374 reported for 2025 was more than what 89% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.90 · 2020: $79.96 · 2021: $15.94 · 2022: $242 · 2023: $366 · 2024: $71.69 · 2025: $374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $792 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $792.34 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $382.52 | 2022-2025 | Anzupgo, Adbry |
| Abbvie INC. | $163.76 | 2023-2025 | |
| Merz North America, INC. | $136.59 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $124.98 | 2022 | |
| Janssen Biotech, INC. | $103.27 | 2022-2023 | Stelara |
| Ucb, INC. | $90.59 | 2025 | Bimzelx |
| Allergan, INC. | $45.90 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $42.73 | 2023-2025 | Bridion |
| Qol Medical, LLC | $29.31 | 2025 | Sucraid |
| Takeda Pharmaceuticals U.S.A., INC. | $24.40 | 2023 | Entyvio |
| Sun Pharmaceutical Industries INC. | $21.42 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.